EDRN Strategic Plan

Developing a collaborative network is a challenging, if not a daunting task. Identifying biomarkers involves a rigorous process that begins with discovery and leads to development, validation, and finally application in the clinic. The success of this process requires a complex, dedicated infrastructure that facilitates coordination and collaboration among a variety of institutions and academic- and industry-based scientists and clinicians. EDRN has fulfilled these expectations by establishing a process for biomarker development using a multidisciplinary and multi-institutional approach. This infrastructure, combined with the development of a highly interactive database and informatics system through EDRN’s collaboration with the Jet Propulsion Laboratory (JPL), serves as a model for the conduct of translational research and is well- aligned with the goals and objectives of the National Cancer Institute (NCI) and the larger National Institutes of Health (NIH) community.
Version 5.1.0